دورية أكاديمية

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.

التفاصيل البيبلوغرافية
العنوان: Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
المؤلفون: Vergote, Ignace, Van Nieuwenhuysen, Els, O'Cearbhaill, Roisin E., Westermann, Anneke, Lorusso, Domenica, Ghamande, Sharad, Collins, Dearbhaile C., Banerjee, Susana, Mathews, Cara A., Gennigens, Christine, Cibula, David, Tewari, Krishnansu S., Madsen, Kristine, Köse, Fatih, Jackson, Amanda L., Boere, Ingrid A., Scambia, Giovanni, Randall, Leslie M., Sadozye, Azmat, Baurain, Jean-François
المصدر: Journal of Clinical Oncology; 12/20/2023, Vol. 41 Issue 36, p5536-5549, 16p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.23.00720